Form 4/A for BSX Boston Scientific
Accepted 2021-08-02 00:00:00 ET · period of report 2021-07-27 · accession 0001225208-21-011029 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2021-08-02 | 2021-07-27 | BSX | Butcher Arthur C | EVP, Pres, Asia Pacific | S - Sale | $45.00 | -9,673 | 25.7K | -27% | -$435.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-27 | S | D | 9,673 | $45.00 | 25,749 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at $45.00 and $45.02. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. On July 27, 2021, the reporting person filed a Form 4 which inadvertently misreported the average sale price of the transactions. In fact, as reported in this amendment, the average sale price was $45.0002. |